Overgrowth of the indigenous gut microbiome and irritable bowel syndrome

World Journal of Gastroenterology

Volumn 20, Issue 10, 2014, Pages 2449-2455

  Bye, William ^a   Ishaq, Naveed ^a   Bolin, Terry D ^a   Duncombe, Vic M ^a   Riordan, Stephen M ^b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Gut microbiome; Irritable bowel syndrome; Small intestinal bacterial overgrowth

Indexed keywords

NEOMYCIN; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; RIFAXIMIN; ANTIINFECTIVE AGENT;

ALISTIPES; ARTICLE; BACTERIAL OVERGROWTH; BIFIDOBACTERIUM; CLOSTRIDIUM; COLLINSELLA AEROFACIENS; COPROCOCCUS EUTACTUS; DYSBIOSIS; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HAEMOPHILUS PARAINFLUENZAE; HUMAN; INTESTINAL DYSMOTILITY; INTESTINAL SECRETION; INTESTINE FLORA; IRRITABLE COLON; LACTOBACILLUS; META ANALYSIS (TOPIC); MICROBIOME; MOLECULAR DIAGNOSIS; NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); RUMINOCOCCUS; STAPHYLOCOCCUS AUREUS; SYSTEMATIC REVIEW (TOPIC); VEILLONELLA; ANIMAL; BACTERIA; CLASSIFICATION; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; INTESTINE MUCOSA; IRRITABLE BOWEL SYNDROME; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MICROFLORA; SMALL INTESTINE; TREATMENT OUTCOME;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIOLOGICAL TECHNIQUES; HUMANS; INTESTINAL MUCOSA; INTESTINE, SMALL; IRRITABLE BOWEL SYNDROME; MICROBIOTA; TREATMENT OUTCOME;

EID: 84896817910     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i10.2449     Document Type: Article

References (35)

1. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. Diversity of the human intestinal microbial flora. Science 2005; 308: 1635-1638 [PMID: 15831718]
2. Rajilić-Stojanović M, Biagi E, Heilig HG, Kajander K, Kekkonen RA, Tims S, de Vos WM. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 2011; 141: 1792-1801 [PMID: 21820992 DOI: 10.1053/ j.gastro.2011.07.043]
3. Malinen E, Rinttilä T, Kajander K, Mättö J, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005; 100: 373-382 [PMID: 15667495]
4. Saulnier DM, Riehle K, Mistretta TA, Diaz MA, Mandal D, Raza S, Weidler EM, Qin X, Coarfa C, Milosavljevic A, Petrosino JF, Highlander S, Gibbs R, Lynch SV, Shulman RJ, Versalovic J. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 2011; 141: 1782-1791 [PMID: 21741921 DOI: 10.1053/ j.gastro.2011.06.072]
5. Jeffery IB, O'Toole PW, Öhman L, Claesson MJ, Deane J, Quigley EM, Simrén M. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 2012; 61: 997-1006 [PMID: 22180058 DOI: 10.1136/ gutjnl-2011-301501]
6. Kassinen A, Krogius-Kurikka L, Mäkivuokko H, Rinttilä T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007; 133: 24-33 [PMID: 17631127]
7. Lyra A, Rinttilä T, Nikkilä J, Krogius-Kurikka L, Kajander K, Malinen E, Mättö J, Mäkelä L, Palva A. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J Gastroenterol 2009; 15: 5936-5945 [PMID: 20014457]
8. Krogius-Kurikka L, Lyra A, Malinen E, Aarnikunnas J, Tuimala J, Paulin L, Mäkivuokko H, Kajander K, Palva A. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol 2009; 9: 95 [PMID: 20015409 DOI: 10.1186/1471-230X-9-95]
9. Malinen E, Krogius-Kurikka L, Lyra A, Nikkilä J, Jääskeläinen A, Rinttilä T, Vilpponen-Salmela T, von Wright AJ, Palva A. Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome. World J Gastroenterol 2010; 16: 4532-4540 [PMID: 20857523 DOI: 10.3748/wjg.v16.i36.4532]
10. Rinttilä T, Lyra A, Krogius-Kurikka L, Palva A. Real-time PCR analysis of enteric pathogens from fecal samples of irritable bowel syndrome subjects. Gut Pathog 2011; 3: 6 [PMID: 21518462 DOI: 10.1186/1757-4749-3-6]
11. Carroll IM, Ringel-Kulka T, Keku TO, Chang YH, Packey CD, Sartor RB, Ringel Y. Molecular analysis of the luminaland mucosal-associated intestinal microbiota in diarrheapredominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2011; 301: G799-G807 [PMID: 21737778 DOI: 10.1152/ajpgi.00154.2011]
12. Simrén M, Barbara G, Flint HJ, Spiegel BM, Spiller RC, Vanner S, Verdu EF, Whorwell PJ, Zoetendal EG. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013; 62: 159-176 [PMID: 22730468 DOI: 10.1136/ gutjnl-2012-302167]
13. McFarland LV, Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol 2008; 14: 2650-2661 [PMID: 18461650]
14. Brenner DM, Moeller MJ, Chey WD, Schoenfeld PS. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am J Gastroenterol 2009; 104: 1033-1049; quiz 1050 [PMID: 19277023 DOI: 10.1038/ ajg.2009.25]
15. Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, Quigley EM. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010; 59: 325-332 [PMID: 19091823 DOI: 10.1136/ gut.2008.167270]
16. Ford AC, Spiegel BM, Talley NJ, Moayyedi P. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2009; 7: 1279-1286 [PMID: 19602448 DOI: 10.1016/ j.cgh.2009.06.031]
17. Yamini D, Pimentel M. Irritable bowel syndrome and small intestinal bacterial overgrowth. J Clin Gastroenterol 2010; 44: 672-675 [PMID: 20838236 DOI: 10.1097/ MCG.0b013e3181ef3476]
18. Riordan SM, McIver CJ, Walker BM, Duncombe VM, Bolin TD, Thomas MC. The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol 1996; 91: 1795-1803 [PMID: 8792701]
19. Yu D, Cheeseman F, Vanner S. Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut 2011; 60: 334-340 [PMID: 21112950 DOI: 10.1136/gut.2009.205476]
20. Vanner S. The lactulose breath test for diagnosing SIBO in IBS patients: another nail in the coffin. Am J Gastroenterol 2008; 103: 964-965 [PMID: 18371132 DOI: 10.1111/ j.1572-0241.2008.01798.x]
21. Posserud I, Stotzer PO, Björnsson ES, Abrahamsson H, Simrén M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007; 56: 802-808 [PMID: 17148502]
22. Kerckhoffs AP, Visser MR, Samsom M, van der Rest ME, de Vogel J, Harmsen W, Akkermans LM. Critical evaluation of diagnosing bacterial overgrowth in the proximal small intestine. J Clin Gastroenterol 2008; 42: 1095-1102 [PMID: 18936644 DOI: 10.1097/MCG.0b013e31818474d7]
23. Choung RS, Ruff KC, Malhotra A, Herrick L, Locke GR, Harmsen WS, Zinsmeister AR, Talley NJ, Saito YA. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther 2011; 33: 1059-1067 [PMID: 21395630 DOI: 10.1111/ j.1365-2036.2011.04625.x]
24. Pyleris E, Giamarellos-Bourboulis EJ, Tzivras D, Koussoulas V, Barbatzas C, Pimentel M. The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. Dig Dis Sci 2012; 57: 1321-1329 [PMID: 22262197 DOI: 10.1007/ s10620-012-2033-7]
25. Kerckhoffs AP, Samsom M, van der Rest ME, de Vogel J, Knol J, Ben-Amor K, Akkermans LM. Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol 2009; 15: 2887-2892 [PMID: 19533811]
26. Kerckhoffs AP, Ben-Amor K, Samsom M, van der Rest ME, de Vogel J, Knol J, Akkermans LM. Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome. J Med Microbiol 2011; 60: 236-245 [PMID: 20947663 DOI: 10.1099/lmm.0022848-0]
27. Husebye E. Gastrointestinal motility disorders and bacterial overgrowth. J Intern Med 1995; 237: 419-427 [PMID: 7714466]
28. Riordan SM, McIver CJ, Wakefield D, Bolin TD, Duncombe VM, Thomas MC. Small intestinal bacterial overgrowth in the symptomatic elderly. Am J Gastroenterol 1997; 92: 47-51 [PMID: 8995936]
29. Mariat D, Firmesse O, Levenez F, Guimarǎes V, Sokol H, Doré J, Corthier G, Furet JP. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol 2009; 9: 123 [PMID: 19508720 DOI: 10.1186/1471-2180-9-123]
30. George SE, Walsh DB, Stead AG, Claxton LD. Effect of ampicillin-induced alterations in murine intestinal microbiota on the survival and competition of environmentally released pseudomonads. Fundam Appl Toxicol 1989; 13: 670-680 [PMID: 2515984]
31. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebocontrolled study. Am J Gastroenterol 2003; 98: 412-419 [PMID: 12591062]
32. Sharara AI, Aoun E, Abdul-Baki H, Mounzer R, Sidani S, Elhajj I. A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol 2006; 101: 326-333 [PMID: 16454838]
33. Pimentel M, Park S, Mirocha J, Kane SV, Kong Y. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med 2006; 145: 557-563 [PMID: 17043337]
34. Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, Mareya SM, Shaw AL, Bortey E, Forbes WP. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med 2011; 364: 22-32 [PMID: 21208106 DOI: 10.1056/NEJMoa1004409]
35. Bonfrate L, Tack J, Grattagliano I, Cuomo R, Portincasa P. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Scand J Gastroenterol 2013; 48: 995-1009 [PMID: 23964766 DOI: 10.310 9/00365521.2013.799220